Laborate Pharmaceuticals India Ltd. is a vertically integrated pharmaceutical manufacturer with four decades of WHO-GMP certified production experience, serving regulated healthcare markets across 35+ countries.
Our five production facilities across Panipat and Paonta Sahib deliver 1,000+ formulations — spanning oral solid dosage, liquids, sterile injectables, and API dosage forms. Nine WHO-Prequalified products enable direct supply to UN procurement agencies and government health ministries.
Institutional, government tender, and UN agency supply
Own-label and third party manufacturing (full QMS)
Dedicated export operations and new market entry support
Our Business Lines
Explore Our Business Areas
Two dedicated service lines — each with a focused team, specialist capabilities, and a proven track record in international pharmaceutical markets.
Contract Development & Manufacturing
Full-service CDMO capabilities — from formulation development and technology transfer to commercial-scale contract manufacturing at WHO-GMP certified facilities across five plants.
Strategic distribution partnerships across 35+ markets — enabling pharma distributors, hospital procurement teams, and institutional buyers to access our 1,500+ product portfolio with full regulatory support.
Select the model that fits your business objectives, regulatory requirements, and market ambitions.
Contract Development & Manufacturing (CDMO)
Full development lifecycle
Ideal for: Biotech companies, branded pharma, EU market entrants
Formulation development, process scale-up, and commercial-scale contract manufacturing at WHO-GMP certified facilities — including bioequivalence coordination and regulatory submission support.
GMP-compliant own-label and third party manufacturing under your brand or specification — with full batch documentation, QMS support, and regulatory dossier assistance.
Ideal for: Ministries of Health, UN agencies, procurement bodies
Large-volume supply to government tenders and UN agency programmes — WHO-PQ products, full documentation, and compliance with donor agency procurement standards.
Ideal for: Importers, regional wholesalers, new market entrants
Established export operations with in-house dossier preparation, product registration, and logistics support — across Africa, the Middle East, Central Asia, and Southeast Asia.
EU ExportRegulated MarketsDossier Support60+ Markets
Ideal for: National distributors, healthcare chains, pharmacy networks
Exclusive or non-exclusive distribution rights for Laborate's branded and generic portfolio — supported by marketing materials, regulatory documentation, and dedicated account management.
Established export and partnership operations in six regions — backed by in-country regulatory registrations, dedicated logistics, and business development support.
South & Southeast Asia
8 active markets
Bangladesh, Myanmar, Sri Lanka, Nepal, Cambodia, Vietnam, Thailand, Philippines
Middle East & North Africa
9 active markets
Saudi Arabia, UAE, Egypt, Jordan, Kuwait, Oman, Qatar, Yemen, Iraq
Full market list and registration status available on request.
Why Laborate
Built for Enterprise Partnerships.
Every partnership is supported by dedicated teams and structured services — from regulatory affairs to supply chain management.
Regulatory Support
Dedicated Key Account Manager
Technical Team Access
Artwork Assistance
Export Documentation
Quality Systems (GMP / ISO)
Pharmacovigilance
Supply Chain Reliability
Engagement Workflow
From Enquiry to First Shipment.
A six-stage engagement process designed for regulated pharmaceutical markets — structured, documented, and transparent at every step.
Day 1
1
Initial Enquiry
Submit requirements via the Business Development portal — product, market, volume, timeline.
Days 2–5
2
Discovery
Requirements assessment, commercial fit evaluation, and preliminary product feasibility.
Weeks 2–3
3
Technical Review
Facility capability review, QMS assessment, sample submission, and dossier evaluation.
Week 4
4
Commercial Proposal
Formal proposal: pricing, MOQs, lead times, documentation schedule, and commercial terms.
Weeks 5–6
5
Agreement
Contract execution, quality agreement, regulatory onboarding, and account setup.
From Week 7
6
Execution
Production, quality release, shipment, and ongoing account management with your KAM.
Partnership Outcomes
Measurable Results, Not Marketing Language.
Selected partnership outcomes across CDMO engagements, government tender supply, and international export programmes.
Export Partnership
East Africa
Essential Medicine Supply — East Africa Public Health Programme
Customer Type
Ministry of Health / Public Health Programme
Product Category
Essential Medicines — Anti-malarials, Antibiotics
Engagement
WHO-PQ supply, full regulatory documentation, donor compliance
12 Million
Units supplied — Year 1 of programme
CDMO
European Union
CDMO Engagement — European Branded Pharmaceutical Group
Customer Type
Branded Pharmaceutical Company (EU-headquartered)
Product Category
Oral Solid Dosage — tablet formulation for EU market
Engagement
Formulation development, BE study coordination, commercial-scale manufacture
18 Months
From first brief to commercial market launch
Government Tender
Southeast Asia
National Procurement Contract — Cambodia Ministry of Health
Customer Type
National Government — Ministry of Health
Product Category
Anti-malarials — artemether-lumefantrine (WHO-PQ)
Engagement
National essential medicine tender; WHO-PQ compliance
USD 2.8M
Contract value — Year 1
Common Questions
Answers for Procurement & BD Teams.
Practical answers to the most common questions from potential partners, distributors, and procurement offices.
What are the minimum order quantities for contract manufacturing?
MOQs vary by product type, dosage form, and manufacturing complexity. For oral solid dosage forms, typical MOQs begin at 500,000 tablets or capsules per batch. Sterile injectable formulations carry higher thresholds due to production line requirements. Our business development team can confirm specific MOQs based on your product specification.
What regulatory documentation does Laborate provide for export markets?
Standard documentation includes Certificate of Pharmaceutical Product (CPP), Certificate of GMP compliance, product registration dossiers (CTD/eCTD format), stability data packages, analytical method validations, and batch records. Our regulatory team supports dossier submission across 60+ markets.
Which international markets does Laborate currently supply?
Laborate maintains active export operations across 35+ countries in South Asia, Middle East and North Africa, Sub-Saharan Africa, Central Asia, Southeast Asia, and Latin America. A full market list with registration status is available on request from our Business Development team.
Can Laborate assist with product registration in new markets?
Yes. Our regulatory affairs team provides end-to-end support for new market registration — CTD dossier preparation, submission management, and liaison with local regulatory authorities across 60+ markets. We can advise on the most efficient registration pathway for your target market.
What does a partner quality audit of Laborate's facilities involve?
Laborate welcomes partner quality audits. Our standard programme includes facility walkthrough, QMS documentation review, access to batch records and deviation reports, regulatory inspection history, and direct dialogue with Quality Assurance leadership. We maintain open-book transparency with all manufacturing partners.
What CDMO services does Laborate offer for novel formulations?
Our CDMO capability covers the full development lifecycle: formulation design, pre-formulation studies, analytical method development and validation, pilot and scale-up manufacturing, ICH stability studies, bioequivalence study coordination, and commercial-scale production. Core expertise in oral solid dosage, liquids, and sterile injectables.
Start the Conversation
Ready to Explore a Partnership?
Contact our Business Development team — we respond to every enquiry within one business day and can schedule an initial discovery call within 48 hours.
